Total Payments
$7,815
2024 Payments
$4,162
Companies
22
Transactions
326
Medicare Patients
1,032
Medicare Billing
$84,252
Payment Breakdown by Category
Food & Beverage$7,715 (98.7%)
Education$99.99 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,715 | 325 | 98.7% |
| Education | $99.99 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,296 | 106 | $0 (2024) |
| QOL Medical, LLC | $916.68 | 39 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $834.57 | 41 | $0 (2024) |
| Ardelyx, Inc. | $710.42 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $477.57 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $365.40 | 16 | $0 (2024) |
| GENZYME CORPORATION | $296.44 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $263.23 | 10 | $0 (2024) |
| PFIZER INC. | $209.84 | 11 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $207.89 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,162 | 182 | ABBVIE INC. ($1,194) |
| 2023 | $2,930 | 122 | ABBVIE INC. ($628.58) |
| 2022 | $597.40 | 21 | ABBVIE INC. ($473.27) |
| 2021 | $125.00 | 1 | Novo Nordisk Inc ($125.00) |
All Payment Transactions
326 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.57 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: GI | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $44.57 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.68 | General |
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 517 | 645 | $178,614 | $43,481 |
| 2022 | 6 | 445 | 542 | $167,954 | $36,437 |
| 2021 | 4 | 70 | 83 | $19,498 | $4,333 |
Total Patients
1,032
Total Services
1,270
Medicare Billing
$84,252
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 296 | $69,672 | $18,163 | 26.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 80 | 83 | $28,201 | $7,189 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 73 | $25,591 | $4,748 | 18.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 34 | $17,395 | $3,908 | 22.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 73 | $14,334 | $3,851 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $12,000 | $2,592 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $7,825 | $1,916 | 24.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 35 | $3,596 | $1,115 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 160 | $62,072 | $13,836 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 166 | $44,948 | $9,426 | 21.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 64 | 64 | $20,544 | $4,438 | 21.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 43 | 45 | $19,530 | $4,208 | 21.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 73 | $16,644 | $3,620 | 21.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 29 | 34 | $4,216 | $909.49 | 21.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $7,378 | $1,614 | 21.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 21 | $4,788 | $1,054 | 22.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 26 | 33 | $4,092 | $884.40 | 21.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $3,240 | $781.44 | 24.1% |
About Lesly Wood
Lesly Wood is a Nurse Practitioner healthcare provider based in Fall River, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2021. The National Provider Identifier (NPI) number assigned to this provider is 1922678564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lesly Wood has received a total of $7,815 in payments from pharmaceutical and medical device companies, with $4,162 received in 2024. These payments were reported across 326 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($7,715).
As a Medicare-enrolled provider, Wood has provided services to 1,032 Medicare beneficiaries, totaling 1,270 services with total Medicare billing of $84,252. Data is available for 3 years (2021–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Gerontology
- Location Fall River, MA
- Active Since 06/27/2021
- Last Updated 05/27/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922678564
Products in Payments
- SKYRIZI (Biological) $995.13
- RINVOQ (Biological) $730.45
- IBSRELA (Drug) $710.42
- XIFAXAN (Drug) $640.52
- Sucraid (Drug) $493.76
- DUPIXENT (Biological) $431.41
- STELARA (Biological) $426.24
- SUCRAID (Drug) $422.92
- ENTYVIO (Biological) $338.13
- CREON (Drug) $244.71
- XELJANZ (Drug) $209.84
- VOQUEZNA (Drug) $207.89
- LINZESS (Drug) $197.16
- TRULANCE (Drug) $194.05
- ZEPOSIA (Drug) $175.38
- OMVOH (Drug) $166.28
- VIBERZI (Drug) $128.82
- Epclusa (Drug) $125.00
- Ozempic (Drug) $125.00
- FARXIGA (Drug) $120.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Fall River
Melanie Araujo, N.p, N.P
Nurse Practitioner — Payments: $9,198
Nurse Practitioner $9,198
Alyson Mandel, N.p, N.P
Nurse Practitioner — Payments: $5,366
Nurse Practitioner $5,366
Ms. Kelly Walker, Np, NP
Nurse Practitioner — Payments: $4,301
Nurse Practitioner $4,301
Teresa Ferreira, Np, NP
Nurse Practitioner — Payments: $2,376
Nurse Practitioner $2,376
Ms. Patricia Grindell, Aprn-Bc, Adm, APRN-BC, ADM
Nurse Practitioner — Payments: $2,355
Nurse Practitioner $2,355
Maria Reis, N.p, N.P
Nurse Practitioner — Payments: $2,205
Nurse Practitioner $2,205